Immediate Impact

19 by Nobel laureates 43 from Science/Nature 87 standout
Sub-graph 1 of 21

Citing Papers

From discoveries in ageing research to therapeutics for healthy ageing
2019 StandoutNature
Pathogenetic insights from the treatment of rheumatoid arthritis
2017 Standout
1 intermediate paper

Works of Helen Travers being referenced

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: Results of a forty‐eight–week randomized, double‐blind, placebo‐controlled, parallel‐group phase III trial
2012
Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double‐blind, methotrexate‐controlled study of patients with active rheumatoid arthritis
2009

Author Peers

Author Last Decade Papers Cites
Helen Travers 444 152 73 329 252 16 890
Setareh Shamsili 359 47 57 252 645 13 1.0k
Susanne Kleber 601 117 141 136 77 15 1.1k
Lorenza Freddo 554 41 93 371 555 16 1.2k
Vivian Tseveleki 336 67 74 102 77 19 836
Toru Iwaki 298 132 100 113 192 20 852
Stefanie Gaupp 204 75 50 146 117 17 1.0k
Bruno Dipasquale 427 21 43 276 94 17 1.1k
Erik Wallstroem 224 138 39 135 209 20 985
Nora P. Dooley 445 75 72 91 76 14 1.1k
Anja Moldenhauer 206 62 21 116 189 24 762

All Works

Loading papers...

Rankless by CCL
2026